Detection of neurofilament autoantibodies in human serum following chemically induced neurologic disorder: A case report

Environmental Epidemiology and Toxicology

Volumn 2, Issue 1, 2000, Pages 37-41

  Abou Donia, Mohamed B ^a   Garrettson, Lorne K ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoantibodies; Chlorpyrifos; Neurofilaments; Organophosphates

Indexed keywords

AUTOANTIBODY; NEUROFILAMENT PROTEIN; ORGANOPHOSPHATE PESTICIDE; PESTICIDE; TRI ORTHO CRESYL PHOSPHATE;

ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; CASE REPORT; CHILD; DEGENERATIVE DISEASE; HUMAN; IMMUNOBLOTTING; NEUROLOGIC DISEASE; NEUROTOXICITY; PRIORITY JOURNAL; SERUM;

EID: 0034083359     PISSN: 15227987     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Abou-Donia M.B. Organophosphorus ester-induced delayed neurotoxicity. Annu. Rev. Pharmacol. Toxicol. 1981: 21: 511-548.
2. Abou-Donia M.B. Involvement of cytoskeletal proteins in the mechanisms of Organophosphorus ester-induced delayed neurotoxicity. Clin. Exp. Pharmacol. Physiol. 1993: 22: 358-359.
3. Abou-Donia M.B., and Graham D.G. Delayed neurotoxicity of O-ethyl O-4-nitrophenyl phenylphosphothioate: subchronic (90 days) oral administration in hens. Toxicol. Appl. Pharmacol. 1978: 45: 685-700.
4. Abou-Donia M.B., and Graham D.G. Delayed neurotoxicity of O-ethyl O-4-nitrophenyl phenylphosphorothioate: toxic effects of a single oral dose on the nervous system of hens. Toxicol. Appl. Pharmacol. 1979: 48: 57-60.
5. Abou-Donia M.B., and Lapadula D.M. Mechanisms of Organophosphorus ester-induced delayed neurotoxicity: type I and type II. Annu. Rev. Pharmacol. Toxicol. 1990: 30: 405-440.
6. Abou-Donia M.B., and Wilmarth K.R. The joint action of chlorpyrifos and safrotin on the development of delayed neurotoxicity in the hen. Toxicologist 1995: 15: 205.
7. Abou-Donia M.B., Graham D.G., Makkawy H.A., and Abdo K.M. Effect of subchronic dermal application of O-ethyl O-4-nitrophenyl phenylphosphorothiate on producing delayed neurotoxicity in hens. Neurotoxicology 1983: 4: 247-260.
8. Abou-Donia M.B., Abdel-Rahman A.A., Abou-Donia S.M., and Jensen K.F. Dose-response study of propetamphos/chlorpyrifos delayed neurotoxicity in the hen. Toxicol. Sci. 1998: 42: 343.
9. Aiuto L.A., Pavlakis S.G., and Boxer R.A. Life-threatening Organophosphorus-induced delayed polyneuropathy in a child after accidental chlorypyrifos ingestion. J. Pediatr. 1993: 122: 658-660.
10. Bahmanyar S., Moreau-Dubois M.C., Brown P., Cathala F., and Gajdusek D.C. Scrum antibodies of neurofilament antigens in patients with neurological and other diseases and in healthy controls. J. Neuroim-munol. 1983: 5: 191-196.
11. Bischoff A. The ultrastrucrure of the tri-ortho-cresyl phosphate poisoning studies on myelin and axonal alterations in the sciatic nerve. Acta Neuropathol. 1967: 9: 158-174.
12. Bischoff A. Ultrastrucrure of the tri-ortho-cresyl phosphate poisoning: II. Studies on spinal alterations. Acta Neuropathol. 1970: 15: 142-155.
13. Budavari S. Creosote, Coal Tar. The Merck Index, 11th edn., 1989, p. 403.
14. Capodicasa E., Scapellato M.L., Moretto A., Caroldi S., and Lotti M. Chlorypyrifos-induced delayed polyneuropathy. Arch. Toxicol. 1991: 65: 150-155.
15. Chiu F.C., and Norton W.T. Bulk preparation of CNS cytoskeleton and the separation of individual neurofilament proteins by gel filtration dye binding characteristics and amino acid compositions. J. Neurochem. 1982: 39: 1252-1260.
16. Cisk V., Motika D., and Marosi G.Y. Delayed neuropathy after trichorfon intoxication. J. Neural Neurosurg. Psychiatry 1986: 49: 222.
17. Elizan T.S., Casals J., and Yahr M.D. Antineurofilament antibodies in postence phalitic and idiopathic Parkinson's disease. J. Neurol. Sci. 1983: 59: 341-347.
18. Fikes J.D., Zachary J.F., Parker A.J., and Beasley V.R. Clinical, biochemical, electrophysiologic, and histologic assessment of chlorpyrifos-induced delayed neuropathy in the cat. Neurotoxicology 1992: 13: 663-678.
19. Fujinami R.S., Oldstone M.B.A., Wroblewska Z., Frankle M.E., and Koprowski H. Molecular mimicry in virus infection: cross -reactions of measles virus phosphoprotein or herpes simplex virus protein with human intermediate filaments. Proc. Natl. Acad. Sci. U.S.A. 1983: 80: 2346-2350.
20. 2+ / calmodulin-dependent phosphorylation by brain supernatant of diisopropyl phosphorofluoridate (DFP)-treated hens: tau mutant indicates phoshorylation of more amino acids in tau by CaM kinase II. Brain Res. 1998: 813: 32-43.
21. Jedrzejowska H., Rowinska-Marcinska K., and Hoppe B. Neuropathy due to phytosol (Agritox): report of a case. Acta Neuropathol. (Berlin) 1980: 49: 1163-1168.
22. Jenson K.F., Haykal-Coats N., Lapadula D.M., and Abou-Donia M.B. Anomalous phosphorylated neurofilament aggregates in central and peripheral axons of hens treated with tri-ortho-cresyl phosphate (TOCP). J. Neurosci. Res. 1992: 33: 455-460.
23. Johnson M.K., and Barnes J.M. Age and sensitivity of chicks to the delayed neurotoxic effects on some organophosphorus compounds. Biochem. Pharmacol. 1970: 19: 3045-3047.
24. Kaplan J.G., Kessler J., Rosenberg N., and Schaumburg H.H. Sensory neuropathy associates with Dursban (chlorpyrifos) exposure. Neurology 1993: 43: 2193-2196.
25. Kurki P., and Virtanen I. The detection of human antibodies against cytoskeletal components. J. Immunol. Methods 1984: 67: 209-223.
26. Lapadula D.M., Suwita E., and Abou-Donia M.B. Evidence for multiple mechanisms responsible for 2,5-hexanedione-induced neuropathy. Brain Res. 1988: 123-131.
27. Liem R.K.H., and Hutchinson S.B. Purification of individual components of the neurofilament triplet: filament assembly from the 70,000-Dalton sub-unit. Biochemistry 1982: 21: 3221-3226.
28. Linder E., Kurki P., and Anderson L.C. Autoantibody to "intermediate filaments" in infectious mononucleosis. Clin. Immunol. Immunopathol. 1979: 14: 411-417.
29. Lotti M., Moretto A., Zoppellari R., Rizzuto N., and Barusco G. Inhibition of lymphatic neuropathy target esterase predicts the development of organophosphate-induced delayed polyneuropathy. Arch. Toxicol. 1986: 59: 176-179.
30. Perov O.V. Changes in antioxidative activity of cells and functions of the nucleus by the action of sub-toxic doses of phenol-pyridine mixtures from coal tar. Bull. Exp. Biol. Med. 1972: 73: 267-270.
31. Pinski C., and Bose R. Pyridine and other coal constituents as free radical-generating environmental neurotoxicants. Mol. Cell Biochem. 1988: 84: 217-222.
32. Prineas J. The pathogenesis of dying-back polyneuropathies. An ultrastructural study of experimental TOCP intoxication in the cat. J. Neuropathol. Exp. Neurol. 1969: 28: 571-597.
33. Reagan K.E., Wilmarth K.R., Friedman M., and Abou-Donia M.B. Acrylamide increases in vitro calcium and calmodulin-dependent kinase-mediated phosphorylation of rat brain and spinal cord neurofilament proteins. Neurochem. Int. 1994: 25: 133-143.
34. Reagan K.E., Wilmarth K.R., Friedman M., and Abou-Donia M.B. In vitro calcium and calmodulin-dependent kinase-mediated phosphorylation of rat brain and spinal cord neurofilament proteins is increased by glycidamide administration. Brain Res 1995: 671: 12-20.
35. Selkoe DJ., and Shelanski M.L. In: (Nandy K., and Sherwin I., Eds.), The Aging Brain and Senile Dementia, Plenum Press, New York, 1977, p. 247.
36. Smith M.I., Elvove E., and Frazier W.H. The pharmacological action of certain phenol esters with special reference to the etiology of so-called ginger paralysis. Public Health Rep. US: 1930: 2509-2524.
37. Sotelo J., Gibbs Jr. C.J., and Gajdusek D.C. Autoantibodies against axonal neurofilaments in patients with kuru and Creutzfeldt-Jacob disease. Science 1980: 210: 190-193.
38. Stefansson K., Marion L.S., Dieperink M.E., Molnar O.K., Schlaepfer W.W., and Helgason C.M. Circulatory autoantibodies to the 200,000-Dalton protein of neurofilaments in the serum of healthy individuals. Science 1985: 228: 1117-1119.
39. Toh B.H., Gibbs Jr. C.J., Gajdusek D.C., Goudsmit J., and Dahl D. The 200- and 150-kDa neurofilament proteins react with IgG autoantibodies from patients with Kuru, Creutzfeldt-Jacob disease, and other neurologic diseases. Proc. Natl. Acad. Sci. U.S.A. 1985: 82: 3485-3489.
40. Towbin H., Staehelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U.S.A. 1979: 76: 4350-4354.
41. Willard M., and Simon C. Antibody detection of neurofilaments. J. Cell Biol. 1981: 89: 198-205.
42. 2+ /calmodulin-dependent kinase phosphorylation of cytoskeletal proteins in the rat central nervous system. Brain Res. 1993: 628: 293-300.